• Protocols

• UW21051

  OPEN TO ACCRUAL

  Phase 1/2 Study LY3537982 in pts w/KRAS G12-C-Mutant Advanced Solid Tumors
  
  

• UW22168

  OPEN TO ACCRUAL

  PH1 Study of ASP3082 in pts w/KRAS G12D Mutant Previously Treated Advanced/Metastatic Solid Tumors